Selectmen unanimously approved an increase to the gas and liquid fuel to be stored at Nano-C. Read more >>
Results from a recent study showed potential to lower aquaculture feed costs and provide a new sustainable alternative protein source.
A study showed results for the first time that a single-cell protein could replace a key ingredient in aquaculture feeds for fish and shrimp. The study looked at KnipBio Meal as a food for white shrimp, Atlantic salmon, and smallmouth grunts. Read more >>
Large scale production of a single cell organism could reduce the need to use wild-caught fish and agricultural crops as the key protein ingredients in aquaculture feeds, according to a new study published in PEERJ today.
The study, entitled A Transdisciplinary Approach To The Initial Validation Of A Single Cell Protein As An Alternative Protein Source For Use In Aquafeeds, is the result of a collaboration between researchers at a Massachusetts-based biotechnology company – KnipBio, Inc – the New England […]
Payton Crum, a 7-year-old first grader, got her best surprise yet Tuesday — hi-tech glasses that will help improve her vision.
As a result of the surprise, she was able to clearly Easter eggs for the first time.
“I love how you can make it farther, bigger and colorful and stuff,” Crum said.
Crum filled her pink Easter basket. As her mother holds her hand, the 7-year-old can now control her vision.
“This thing right here, it zooms in and zooms out,” she […]
Regroup Mass Notification, the award-winning leader in emergency and day-to-day mass communication technology, will be presenting an informative webinar to cover the most important aspects of cyber security for organizations. Read more >>
The U.S. Food and Drug Administration needs Corbus Pharmaceuticals to show positive data from only one late-stage study on its experimental treatment for scleroderma to support a marketing application, the company said. Read more >>
Siamab Therapeutics Presents New Preclinical Data for Its Novel Anti-STn Antibodies, Antibody-Drug Conjugates, and Anti-STn Bispecific Antibodies at the AACR Annual Meeting 2017Ziad
Siamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies, today announced the presentation of two posters featuring new preclinical data for its novel anti-Sialyl-Tn (STn) antibodies, antibody-drug conjugates (ADCs), and anti-STn, anti-CD3 bispecific antibodies at the American Association for Cancer Research (AACR) Annual Meeting 2017, being held April 1-5, 2017 in Washington, D.C. Read more >>
Nine-year-old John Paul Corman, who is legally blind, is now experiencing the world through a device called eSight.
It processes images in real-time and allows John Paul to focus where he’s looking.
“eSight takes his little bit of vision and makes it better for him, it gives him more access to the visual world around him,” explains his mother Faye Corman. Read more >>